SCHEMBL20442811

SCHEMBL20442811

Oc1cccc(SCCBr)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
CA12 O43570 2/20 0.42
CA2 P00918 2/20 0.42
CYP3A4 P08684 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
LMNA P02545 1/20 0.42
CA5A P35218 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
CYP19A1 P11511 2/20 0.40
MAPK1 P28482 1/20 0.38
ENPP2 Q13822 1/20 0.36
ACHE P22303 4/20 0.36
TSHR P16473 2/20 0.36
OPRM1 P35372 1/20 0.36
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
CYP2C9 P11712 1/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3166241 0.82 ALDH1A1 (0.44) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL26192746 0.82 ALDH1A1 (0.44) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL29650356 0.82 ALDH1A1 (0.44) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL9806922 0.82 KIF11 (0.49) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL26192998 0.79 CYP3A4 (0.50) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL8079236 0.78 CA2 (0.42) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL19692896 0.77 ALDH1A1 (0.39) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL6659524 0.77 ALDH1A1 (0.39) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL29650290 0.77 ALDH1A1 (0.39) ALDH1A1CA12CA2CYP3A4CA9
SCHEMBL9323120 0.77 MAP1LC3B (0.46) ALDH1A1CA12CA2CYP3A4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018140809-A1 MODULATORS OF ESTROGEN RECEPTOR PROTEOLYSIS AND ASSOCIATED METHODS OF USE Arvinas, Inc. (US) 2018-08-02 WO disclosed